SCHEMBL5651239

SCHEMBL5651239

CN(CC1CCNCC1)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRA1B P35368 1/20 0.39
HRH4 Q9H3N8 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
TMEM97 Q5BJF2 5/20 0.36
SIGMAR1 Q99720 1/20 0.36
NOS3 P29474 1/20 0.34
NOS1 P29475 1/20 0.34
NOS2 P35228 1/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
KDM4E B2RXH2 1/20 0.33
DAO P14920 1/20 0.32
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27391655 0.96 NOS3 (0.35) ADRA1BHRH4HRH3TMEM97SIGMAR1
SCHEMBL27564858 0.92 ADRA1B (0.42) ADRA1BHRH4HRH3TMEM97SIGMAR1
SCHEMBL5645558 0.90 NOS3 (0.33) ADRA1BTMEM97SIGMAR1NOS3NOS1
SCHEMBL25565965 0.90 NOS3 (0.36) ADRA1BNOS3NOS1NOS2SLC6A2
SCHEMBL24350727 0.86 NOS3 (0.42) ADRA1BNOS3NOS1NOS2SLC6A2
SCHEMBL24351757 0.86 NOS3 (0.42) ADRA1BNOS3NOS1NOS2SLC6A2
SCHEMBL3473819 0.85 SLC6A2 (0.37) ADRA1BTMEM97SIGMAR1NOS3NOS1
SCHEMBL13280102 0.85 ADRA1B (0.44) ADRA1BHRH4HRH3TMEM97SIGMAR1
SCHEMBL19720283 0.85 ADRA1B (0.48) ADRA1BHRH4HRH3TMEM97SIGMAR1
SCHEMBL13711904 0.85 ADRA1B (0.48) ADRA1BHRH4HRH3TMEM97SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7279470-B2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2007-10-09 US disclosed
US-7067517-B2 Use of compounds for decreasing activity of hormone-sensitive lipase NERO NORDISK A/S (DK) 2006-06-27 US disclosed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
EP-1458375-A2 COMPOSITIONS FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
WO-2003051842-A2 COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase LIPE, PNLIP, LPL ADRA1B 1910/4885HRH4 2300/4885HRH3 2175/4885
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive LIPE, PNLIP, LPL ADRA1B 1829/4885HRH4 2127/4885HRH3 2294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.